RADON TREATMENT CONTROVERSY by Zdrojewicz, Zygmunt & Strzelczyk, Jadwiga (Jodi)
Dose-Response: An International Journal
Volume 4 | Issue 2 Article 5
6-2006
RADON TREATMENT CONTROVERSY
Zygmunt Zdrojewicz
Katedra i Klinika Endokrynologii i Diabetologii, (Department and Clinic of Endocrinology & Diabetes), Akademia Medyczna
(Medical School), Wroclaw, Poland
Jadwiga ( Jodi) Strzelczyk
University of Colorado at Denver, Denver, CO
Follow this and additional works at: https://scholarworks.umass.edu/dose_response
This Article is brought to you for free and open access by ScholarWorks@UMass Amherst. It has been accepted for inclusion in Dose-Response: An
International Journal by an authorized editor of ScholarWorks@UMass Amherst. For more information, please contact
scholarworks@library.umass.edu.
Recommended Citation
Zdrojewicz, Zygmunt and Strzelczyk, Jadwiga ( Jodi) (2006) "RADON TREATMENT CONTROVERSY," Dose-Response: An
International Journal: Vol. 4 : Iss. 2 , Article 5.
Available at: https://scholarworks.umass.edu/dose_response/vol4/iss2/5
106
RADON TREATMENT CONTROVERSY
Zygmunt Zdrojewicz, MD  Katedra i Klinika Endokrynologii i Diabetologii,
(Department and Clinic of Endocrinology & Diabetes), Akademia Medyczna
(Medical School), ul. Pasteura 4, Wroclaw, Poland
Jadwiga (Jodi) Strzelczyk, PhD  Department of Radiology, Radiological
Sciences Division, School of Medicine, University of Colorado at Denver, Health
Sciences Center, 4200 E. 9th Ave, Denver, Colorado
 In spite of long traditions, treatments utilizing radon-rich air or water have not been
unequivocally embraced by modern medicine. The objective of this work is to examine
factors that contribute to this continuing controversy. While the exact mechanism of
radon’s effect on human body is not completely understood, recent advances in radiobi-
ology offer new insights into biochemical processes occurring at low-level exposures to
ionizing radiation. Medical evidence and patients’ testimonials regarding effectiveness of
radon spa treatments of various ailments, most notably rheumatoid arthritis are accumu-
lating worldwide. They challenge the premise of the Linear-No-Threshold (LNT) theory
that the dose-effect response is the same per unit dose regardless of the total dose.
Historically, such inference overshadowed scientific inquiries into the low-dose region and
lead to a popular belief that no amount of radiation can be good. Fortunately, the LNT
theory, which lacks any scientific basis, did not remain unchallenged. As the reviewed lit-
erature suggests, a paradigm shift, reflected in the consideration of hormetic effects at
low-doses, is gaining momentum in the scientific community worldwide. The impetus
comes from significant evidence of adaptive and stimulatory effects of low-levels of radia-
tion on human immune system.
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INTRODUCTION
Archeological discoveries in Central and Southern Europe suggest
that therapeutic properties of certain waters were well recognized in the
ancient times, but only within the last century high concentrations of
radon were discovered to be present in these waters. Natural and artificial
grottoes, and carved in the rock bathing tubs, found in some of the old-
est spas in this region such as the island of Ischia in the volcanic area near
Naples, Merano [2,000 Bq/L] and Lurisia [4,000 Bq/L] spas in the
alpine region, and others (Pratzel HG and Deetjen P 1997), point to the
use of treatments involving the intake of radon gas through inhalation, or
by transcutaneous resorption of radon dissolved in water.
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HISTORICAL ACCOUNTS PRIOR TO THE DISCOVERY OF RADON
Ancient Greeks enjoyed baths in natural waters for cleansing and
hygienic purposes and took the waters after extensive exercise. With time,
additional benefits were ascribed to bathing. Hippocrates [460-370 BC]
put forth a hypothesis that an imbalance of the bodily fluids was at the
core of all diseases and proposed that a change in the human environ-
ment and lifestyles would help; specific recommended activities included
bathing, perspiration, walking and massages. The Romans, influenced by
these traditions, developed their own multipurpose spa systems. Thermal
baths at mineral and thermal springs were used not only for rest and
recreation, but also served as medical facilities. Around 124 BC, a Greek
physician Asclepiades who practiced in Rome introduced general
hydrotherapy for both therapeutic and preventive purposes, and drink-
ing cures. Hydrotherapy included immersion of the whole body in water
in order to treat rheumatic and urogenital disorders, as well as applica-
tion of water to afflicted parts of the body (Jackson RPJ 1999). 
Interesting possibilities of derivation of the term “spa” are explored
in a recent article published in Annals of the Rheumatic Diseases (Van
Tubergen A and van der Linden S 2002). Among the most plausible is
that “spa” is the acronym of the Latin phrase “sanitas per aquas” [health
through water]. In various literature sources, bathing in thermal waters
for therapeutic purposes is described by different terms such as bal-
neotherapy, spa therapy, hydrotherapy, taking the waters, and others.
Throughout the centuries the interest in the use of water in medicine has
fluctuated from nation to nation and the opinions about these uses
ranged from considering them beneficial to harmful. 
Preceding the discovery of what now is known as radon, and its
reported benefits, there have been numerous observations of detrimen-
tal health among miners in Central Europe. First warnings about “dan-
gerous air in the depth of the earth” were documented in the 15th cen-
tury, and about 1530, the famous Swiss-German physician Paracelsus, or
more properly Theophrastus Phillippus Aureolus Bombastus von
Hohenheim [1493-1541], who practiced in mining towns of the region,
brought “Bergsucht” or “mountain disease” to wider attention. Reports by
other contemporaries followed. Only after the discovery of ionizing radi-
ation and “emanation”, radon became a suspect (Becker 2003).
RADON DISCOVERY AND ITS SIGNIFICANT PROPERTIES
The end of the 19th century was marked by major scientific discover-
ies, of X-rays by a Dutch-German physicist K.W. Roentgen [1845-1923]
and radioactivity by a French scientist A.H. Becquerel [1852-1908] among
them. The discovery of radium [226Ra] by a Polish lady scientist M.
Sklodowska-Curie and her husband, French professor P. Curie followed.
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Only two years later, in 1900, a daughter product of radium, radon [Rn-
222] was discovered by a German chemist F.E. Dorn who called it “radi-
um emanation”. Radon also initially called “niton”, was separated by E.
Rutherford [1871-1937] and F. Soddy [1877-1956] in 1902 (Draganic IG
et. al. 1990).
Radon is an inert gas with atomic number of 86; the mass of the most
stable isotope is 222. It naturally occurs as a result of α decay of 226Ra,
which in turn is derived from the long-lived antecedent, uranium (238U)
as depicted in Figure 1. 
Of the three naturally occurring radon isotopes, 219Rn [actinon, half-
life under 4 seconds, occurring in the 235U decay series], 220Rn [toron,
half-life of just under 1 minute, occurring in the 232Th decay series], 222Rn
[radon, half-life 3.825 days], the latter, with biological half-life of about 30
minutes, is biologically most significant. 
This colorless, odorless, and chemically inactive gas is 7.6 times heav-
ier than air; it readily dissolves in water, particularly if water is slightly
acidic and not rich in minerals, and in alcohol and fatty acids. Alpha radi-
ation with 5.49 MeV energy emitted by radon operates on short distance
with penetration ability of about 41.1 μm in water and about 20 μm in tis-
sue (Deetjen 1990).
Among radon daughters, 218Po, 214Pb, 214Bi, and 214Po, traditionally
referred to as radium A, radium B, radium C and radium C’, respective-
ly, are most important from the standpoint of balneology as they com-
prise a radioactive sediment. Residence time of radon in human organ-
ism is short—it is estimated that about 59% of radon is eliminated within
15-30 minutes. The final decay of radon in the organism to the level not
 
FIGURE 1: U-238 naturals decay series. Subscripts refer to atomic numbers and superscripts refer to
mass numbers. Half-lives and α or β types of emission are shown in parentheses. All members of the
series also emit one or more γ except Bi-210 and stable Pb-206. All β emissions are β-1 (after
Hallenbeck 1994).
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detectable by analytic methods takes place within 2-3 hours. After that
time, only the sediment remains in the system; it emits mostly α and β
radiation, and photons only to a minor extent, during the first 7 hours of
residence in the system, resulting in the creation of radium D+E [210Pb
and 210Bi], which becomes a long-term [half-life of 22.3 years] source of
weak β radiation (Deetjen and Jockel 1992, Hallenbeck 1994).
RECENT UNSETTLING EVENTS
While interest in the bathing culture grew throughout the world dur-
ing the 19th and 20th centuries, the opinions about radon treatments
ranged from very enthusiastic to extremely critical. A number of factors
influenced public opinion.
During the 20th century, high radon concentrations have been
observed in uranium and non-uranium mines, and at uranium milling
sites in Australia [Radium Hill and other uranium mining sites], Canada,
China, Czechoslovakia [now Czech Republic and Slovakia], France,
Germany, Sweden, the U.S. and other countries. It has been theorized
that excess lung cancers among the underground miners results from
exposure to radon and its daughters, 218Po and 214Po in particular. While
there is no doubt that exposures to high radon concentrations contribute
to the increase in lung cancer rates in this population, the degree of this
contribution remains an unresolved issue due to the presence of smoking
(Hallenbeck 1994), exposure to crystalline silica (Bochman 2001), diesel
exhaust (USEPA 2002) and perhaps other carcinogens (Duport 2002). It
is generally accepted among experts that there is no increased lung can-
cer risk at 500-1000 WLM [Working Level Month corresponds to expo-
sure over 170 hours at 1 WL, where Working Level is equal approximate-
ly to 7.4 kBq/m3 or 200 pCi/L] (Becker 2003).
Discoveries of elevated indoor radon levels in Germany in the late
1940s, followed by similar findings in Sweden (Becker 2003) and in the
U.S. [Grand Junction, CO] in the 1950s (Cole 1993), triggered a surge of
scientific and public interest in the residential radon issue. Numerous sur-
veys and epidemiological studies were initiated in various countries
(Marcinowski 1992). Their findings led to meta-analyses (i.e. Lubin LH
and Boice JD 1997) that followed a similar approach to that used by in ear-
lier meta-analyses of underground miner studies. In spite of pitfalls inher-
ent in meta-analyses, inadequate consideration of confounding factors
and dosimetric inadequacies repeatedly pointed out by B. Cohen over the
past ten years (most recently: Cohen B 2005), arbitrary linear extension of
dose-response curve from high dose region to the origin of coordinates
utilized in these analyses, became the basis of official risk models.
The most recent article that used the data pooled from several case-
control studies (Krewski et al. 2005) is cited on the USEPA website link
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(see reference) as providing “direct evidence of an association between
residential radon exposure and lung cancer below EPA’s action level of 4
pCi/L [148 Bq/m3]”. It is further stated in a circulatory manner that
“these results are consistent with radon risk estimates from the EPA’s
Assessment of Risk from Radon at Homes (EPA 402-R-03-003, June 2003),
and the Health Effects of Exposure to Radon: BEIR VI, National Research
Council, NAS 1999”.
Lung cancer is the leading cause of cancer deaths in American men
and women (ACS website, CDC-National Vital Statistics Report 2003). A
number of factors are associated with differences in the rates, including
age, gender, racial/ethnic origin, and geographic location. According to
a published by the EPA map, Colorado is one of the states with high resi-
dential radon concentrations. Indeed, only 12 out of 62 counties have
radon concentration levels below 4pCi/L [148 Bq/m3] thus one would
anticipate higher rates of lung cancer in the state. 
On contrary, the overall incidence rate in Colorado was 54.7 versus
67.7 nationwide, per 100,000, in 2001. The 1999-2001 data available for
the counties indicate that the average annual rate for the state was 53.1
per 100,000 with only 5 counties exceeding the U.S. incidence rate.
Three of these counties were sites of extensive uranium mining and/or
milling activities: Fremont [Cotter Mill], Mesa [Climax Uranium Mill],
and Moffat [Maybell Mill]. It seems likely that some of the excess of lung
cancer in these counties can be attributed to occupational rather than
residential radon exposures.
The annual death rate due to lung and bronchus cancer in Colorado
[41.8 per 100,000 in the 1998-2002 period] met the Healthy People 2010
objective No. 03-02 [44.9] (CDC), while the national death rate was con-
siderably higher [55.7 per 100,000]. None of the Colorado counties
exceeded the annual U.S. death rate during this period. 
The Colorado example suggests that EPA’s assumption of radon risk
estimates at low levels is speculative. Similar observations regarding
inconsistencies in alleged radon health threat have been made in other
parts of the world, most notably in Japan and Iran. Japanese doctors
report that people who live in the Misasa villages, where drinking water
contains high concentration of radon and indoor radon level is about 54
Bq/m3 [1.46 pCi/L], about 3 times higher than the national mean
(Yamaoka et al. 2005), exhibit far lower rates of cancer than elsewhere in
Japan (Mifune et al. 1992), with cancer death rates of 3.66% versus
6.68%. Ramsar, Iran is another example. The region has some of the
highest recorded levels of natural background radiation [i.e. 25 times
higher than the average value for the U.S.], yet there is no increase inci-
dence of leukemia or other cancers in this region (Ghiassi-nejad et al.
2002). Unreasonable assumption of radiation risks at low exposure levels
adds to public’s confusion and mistrust.
Z. Zdrojewicz and J. Strzelczyk
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CURRENT STATUS OF RADON THERAPY
Radioactive radon gas is widely considered to be health hazard by
environmental agencies in the U.S. and Europe (USEPA 1993, Becker
2003). Yet, despite the warnings of these agencies, thousands of people
annually expose themselves to radon for therapeutic purposes in facilities
ranging from rustic old mines to upscale spas and clinics (Erickson 2004).  
It is important to realize that the renewed interest in radon therapy
in recent decades has little relation to the popular fashion in the early
part of 20th century, mostly in Europe that attributed a multitude of heal-
ing powers to radium. In addition to the use of external sources such as
radium-impregnated bed blankets and compresses, Ra intake was prac-
ticed as well. Radium was, for example, added to many “health food”
items and toothpaste (Becker 2004). While some of these uses may be
viewed from the perspective of time as irresponsible, low doses of radia-
tion, though not well controlled, may have been in some way beneficial
to people of that era. 
Well-known curative spas that operated in the last two centuries
remain as historical monuments throughout Europe and other parts of
the world. In many countries in Europe (Germany, Austria, France, Italy,
Hungary, Bulgaria, Poland, the Czech Republic and others), South
America (Chile, Brazil), and Asia (China, Japan) new centers have been
constructed and their operation is frequently harmonized with modern
medical approaches to achieve curative effects.
Among the traditional spas with high radon concentration, Bad
Gastein, Austria is perhaps among the best known. Radon concentration
in the air at the Gastein Healing Gallery averages 43 kBq/m3 [about 1.2
nCi/L] with maximal value of 160 kBq/m3 [about 4.3 nCi/L]. The
breathing air at the gallery has temperature around 40°C and may be sat-
urated with humidity if indicated. A classical cure at the Gallery provides
a guest with a radiation dose of about 2.3 mSv (230 mrem) per year. 
The immersion of the body in thermal water for therapeutic purpos-
es is also practiced at Bad Gastein. Bathing water temperature markedly
exceeds the recommended minimum of 20°C and the concentration on
radon is in the range of 20 nCi/L [740 Bq/L] (Deetjen 1997). 
In numerous descriptions and web advertisements of therapeutic spas
in Europe, concentration of radon in thermal waters is expressed in the
traditional units of Mache, named after German scientist H. Mache
(1876-1954). The Mache unit [ME] is defined as “that quantity of Rn per
liter, which without decay products and with complete utilization of the
α-particles can maintain by its ionization of air a saturation current of 10
e.s.u...” (Curie et al. 1931; p 232). One ME corresponds to 13.5 Bq/L or
364 pCi/L. Thus concentration of radon in therapeutic waters used in
Bad Gastein would be in the range 55 ME.
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Historically, high values of radon concentration have been claimed by
operators of various spas to remain competitive. However, claimed radon
concentrations in the air of caves, former mine shafts, and other under-
ground facilities require careful consideration of the conditions and
duration of the measurements, as relatively large seasonal fluctuations are
possible (Szerbin 1996).
While the concerns of environmental agencies in Europe about the
risks of indoor radon levels are similar to those in the U.S., these con-
cerns do not seem to preclude medical uses of radon. Most European
countries tend to incorporate within their biomedical healthcare systems
many of the genres of treatment categorized in the U.S. as “alternative”
or “complementary” (i.e. homeopathy, manipulative techniques, natur-
opathy); in many countries such therapies are a covered medical benefit.
Radon therapy is an established treatment that builds on centuries-old
spa therapies (Erickson 2004). Many specialists, especially dermatologists
and rheumatologists, now acknowledge the medical significance of
bathing particularly when combined with other treatments such as physi-
cal exercise (Routh et al. 1996).
In addition to previously mentioned Bad Gastein in Austria, the cur-
rently best-known radon treatment centers with medical supervision are:
Bad Hofgastein in Austria; Plombieres in France; Bad Kreunznach, Bad
Munster and Schlema in Germany; Ischia in Italy; Misasa in Japan; and
Pyatigorsk in Russia (Becker 2004). There are numerous other less
known radon therapy centers such as Ikaria in Greece, Jachymov in the
Czech Republic, Jahuel Hot Springs in Chile, Hisarja in Bulgaria, Felix
Spa in Romania and many others.
Many health conditions are treated at these centers, with some suc-
cess (Bad Gastein website link), inflammatory rheumatic illnesses such as
Morbus Berchterew (ankylosing spondylitis), chronic polyarthritis,
fibromyalgia, scleroderma, rheumatoid arthritis, and degenerative and
deforming joint infections [arthrosis, spondylosis, osteochondrosis]
among them. Other types of ailments include neuralgia, chronic pain
such as one experienced as a result of a trauma, as well as respiratory dis-
eases [bronchial asthma, chronic bronchitis, sinusitis], and allergic ill-
nesses such as hay fever and neurodermitis. Treatments of complications
involving the endocrine system, menopausal symptoms, impotence, and
many other conditions are attempted as well.
There are about 40 health resorts or spa towns in Poland that provide
the full range of services. Each facility has a specific profile, natural
resources, a medical balneology department, professional medical staff,
and a unique therapeutic climate for a range of illnesses. Not all engage
in radon treatments. To be classified as a radon mineral water, it must
have a minimum of 2 nCi/L (74 Bq/L) concentration of radon. Radon
baths are typically used for hypertension, rheumatoid arthritis and arte-
Z. Zdrojewicz and J. Strzelczyk
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riosclerosis of lower extremities, and inhalation therapy is often adminis-
tered at speleotherapy centers for conditions such as chronic bronchitis
and bronchial asthma. Compared to baths, inhalation radon is absorbed
at a faster rate via mucous membrane (Ponikowska et al. 2002). 
Among health resorts in the Lower Silesia in the former German lands
in Poland, Szczawno Zdroj [Bad Salzbrunn], Ladek Zdroj [Bad Landeck],
Swieradow (Bad Flinsberg) are among the centers where substantial clini-
cal research is carried out. The latter two resorts, due to high radon con-
tent in water, are particularly attractive to patients with peripheral blood
vessel disease (Joss et al. 2002). Department and Clinic of Endocrinology
and Diabetes of the School of Medicine in Wroclaw [Breslau], Poland is
actively involved in clinical studies of radon in the treatment of endocrine
system disorders (Zdrojewicz and Belowska-Bien 2004a). Some of our
recent findings are included below with those of others.
DO RADON TREATMENTS WORK AND HOW?
Until recently, other than causing lung cancer, the effects of human
exposure to radon received little attention in the scientific literature.
Reports issued more than a decade ago by the United Nations Scientific
Committee on the Effect of Atomic Radiation (UNSCEAR 1993 and
1994) suggested adaptive responses to radiation by cells and organisms.
Results of subsequent clinical trials and molecular-level studies as well as
patients’ testimonials point to beneficial rather than detrimental respons-
es at low-level exposures. No fatalities have been observed due to partici-
pation in radon therapy. 
Waters with radon appear to have analgesic, anti-inflammatory proper-
ties and provide neuro-vegetative balance. Among the conditions that have
been treated in radioactive spas with greatest success, several, including
rheumatoid arthritis, bronchial asthma, psoriasis, are described as having
autoimmune etiology. They are characterized by an excessive response of
the immune system, which then attacks individual’s own cells (Soto 1997). 
In a recent randomized sham-control study of a long-term efficacy of
radon spa therapy in rheumatoid (Franke et al. 2000), subjects partici-
pated in a 4- week program in Bad Brambach, Germany consisting of
complex regimen that included physical therapy. Cases participated in
baths in natural spring water containing on average 1.3 kBq/L. Both
groups showed marked effects at discharge in terms of reduction in pain
intensity, the effects in the control group were short-lasting while cases
enjoyed small to moderate long-lasting effects. 
Studies that combine radon therapy with exercise are of particular
interest for treatment of ankylosing spondylitis as they clearly indicate the
superiority of this approach (Van Tubergen et al. 2001, Van Tubergen
and Hidding 2002).
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Radon therapy appears to aid in the recovery of the immune system.
This is the case with bronchial asthma and even more so in the treatment
of atopic asthma (Marshalick and Fenco 1991), as well as with intestinal
dysbactreriosis (Marshalick and Shkolenko 1993), where long-lasting
effect on the immune system has been demonstrated.
A series of on-going clinical studies involving radon therapy are con-
ducted at the School of Medicine in Wroclaw, Poland. Their purpose is to
investigate the degree of stimulating effect of this approach on the secre-
tion of hormones. In these case-control studies, the regimen for both
groups includes gymnastics and other spa activities. Case subjects under-
go additional cyclical 15-minute immersions in radon water at the tem-
perature of 37°C. These radon therapies are generally performed in
Swieradow Zdroj, where bathing water with about 707 Bq/L [19 nCi/L]
radon concentration is used. The duration of therapy varies with differ-
ent health conditions. 
In a study involving 54 menopausal women treated for trauma-related
motion disorders, radon group showed statistically significant increase in
the concentration of blood estradiol during therapy and only a slight
decrease upon its completion (unpublished work in-progress). Similar
stimulatory effects were observed in a study of 79 men [average age:
48]—a statistically significant increase in testosterone levels was observed
in both controls and cases, though it was more pronounced in the radon
group during therapy. Again, there was a decrease in blood concentration
of testosterone in the radon group upon completion of therapy
(Zdrojewicz and Bielowska-Bien 2004b). These decreases in the level of
estradiol and testosterone upon removal of the stimulatory agent may be
indicative of an adaptive process. The importance of follow-up studies in
this are cannot be overstated. They may provide information on optimal
treatment regimen with maximum duration of benefits. In effort to fur-
ther investigate the effectiveness of radon therapy on the endocrine sys-
tem, prolactin levels were assessed in both men and women, however no
changes in the secretion of this hormone were observed (unpublished
work in-progress). Additional inquiries in this area may provide explana-
tion and perhaps better treatment of many immunological disorders. 
The exact mechanism of radon’s effect on human body is not com-
pletely understood. However, the most favored hypothesis is that radon’s
action is mediated by the neuroendocrine system, stimulation of the
suprarenal glands by the hypophysis, rather than by direct action on the
T cells. Irradiation would act on neurosecretory cells and lead to hor-
monal changes, which would then act on the different T cell subsets
(Soto 1997, Liu et al. 1993). 
The operation of small doses of radiation is complex. On the one
hand, radiation may increase production of free radicals, on the other, it
activates protective mechanisms responsible for their neutralization and
Z. Zdrojewicz and J. Strzelczyk
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it prevents expression of damaging actions of radicals. This mechanism
is the basis of beneficial effects of small doses of ionizing radiation. All
transformations of free radicals are associated with the formation of
reactive oxygen species [ROS] (Halliwell 1994). Free radicals may influ-
ence the transmission of intercellular signals and impact biochemical
processes such as proliferation and apoptosis (Jajte 1997). The main
mechanisms protecting against damaging factors in cells are those that
prevent the formation of ROS, mechanisms that eliminate earlier
formed ROS (catching and extinguishing), and mechanisms that
remove damaged molecules from the system to prevent their accumula-
tion (Bergendi et al. 1999).
Both enzymatic and non-enzymatic protective mechanisms are avail-
able to cells. Among the enzymes, superoxide dismutase (SOD) deserves
particular attention. SOD and p53 gene are considered stress response
proteins. It has been shown that routine exposure to radon induces traces
of active oxygen [in vivo in Misasa, Japan residents]. Elevated p53 levels
indicate potentiating cancer-suppressive gene protein thus apoptosis may
readily occur. While SOD activity generally decreases with age, Misasa
female residents’ SOD activity exceeded the reference range despite
advanced age indicating increased antioxidant function (Yamaoka 2005).
These factors may explain low cancer-related mortality in this region. 
As mentioned earlier, while concerns of environmental agencies
about indoor radon in many parts of the world are similar to those in the
U.S., controlled radon therapy is pursued in a completely different cul-
tural context. In radon curative tunnels such as the Gastein Healing
Gallery in Austria, where radon is inhaled, patients are examined and a
specific dose of radon prescribed for their individual conditions
(Erickson 2004). In the words of Dr. Hornatova, former medical director
of the Radium Palace in the Czech Republic, radon treatment is not con-
sidered “alternative therapy” nor is it considered to be a “nature cure”.
Rather, it is simply one of many science-based treatment possibilities
(Franke 2000).
No medical personnel of any kind are available at the Montana mines
where radon treatment is passive and self-directed. At the better-known
Free Enterprise Radon Health Mine, concentration of radon in the mine
is tested on a regular basis by independent laboratories (Erickson 2004),
with results ranging from 1.1 to 1.6 nCi/L [41-59 kBq/m3]. This repre-
sents 25-37% of the radon concentration at the Gastein Healing Gallery.
According to Erickson (2004), people who use radon therapy in the U.S.
are predominantly elderly, many with chronic illnesses, many of them
report that medications they have been taking lost their effectiveness over
time. 
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CONCLUSIONS
Central to radiation risk estimates based on the LNT hypothesis is the
assumption that the dose-effect response is the same per unit dose regard-
less of the total dose. This suggests that the mechanisms of actions that
induce these responses at low doses and at high doses are the same. This
simply is not the case. Results of new cellular and molecular research indi-
cate that the responses differ at different dose levels and it is possible to
detect corresponding changes in gene regulation. One set responds to
low doses, and another set of genes to high doses; these sets are both up-
and down- regulated by radiation exposure (Aurengo 2005).
In light of recent clinical observations and the newest reports, it is
clear that beneficial action of low doses of radiation clearly outbalances
its potential risk. Hormesis, which is becoming a central issue in toxicol-
ogy (Calabrese and Baldwin 2003), needs to be strongly considered in the
investigations of low-dose radiation effects in humans. Radon therapy
should continue to be studied with an open mind and scientific evidence
for its efficacy diligently collected. Ascribed to Paracelsus phrase “It is the
dose which makes the poison” remains relevant more than ever.
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